Compare LIVN & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIVN | AVNT |
|---|---|---|
| Founded | 1987 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.4B |
| IPO Year | 1993 | 1993 |
| Metric | LIVN | AVNT |
|---|---|---|
| Price | $66.56 | $38.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $67.38 | $45.29 |
| AVG Volume (30 Days) | 615.0K | ★ 915.0K |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | $1,348,962,000.00 | ★ $3,246,100,000.00 |
| Revenue This Year | $12.25 | $2.18 |
| Revenue Next Year | $6.68 | $2.48 |
| P/E Ratio | ★ N/A | $31.13 |
| Revenue Growth | ★ 8.63 | 1.03 |
| 52 Week Low | $32.48 | $27.48 |
| 52 Week High | $67.92 | $44.78 |
| Indicator | LIVN | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 70.83 |
| Support Level | $64.23 | $35.35 |
| Resistance Level | $67.20 | $39.36 |
| Average True Range (ATR) | 1.81 | 1.08 |
| MACD | 0.10 | 0.09 |
| Stochastic Oscillator | 68.65 | 87.27 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.